C. David Hansen
( out of 457 reviews )

C. David Hansen, MD

Languages spoken: English, German

Clinical Locations

Midvalley Health Center

801-581-2955

  • C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

    Specialties

    Board Certification

    American Board of Dermatology (Dermatology)

    Patient Rating

    5.0 /5
    ( out of 457 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 25, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Very thorough and careing

    August 25, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    The greatest of doctors!

    August 24, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    First of all, hes well educated an expert in his field is had many years of practice has an incredible personality really funny, relaxes you and yet knows exactly what hes doing. I really trust this doctor.

    August 23, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    It was very good

    August 23, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen has taken exceptional care of my for over a decade. I trust and appreciate his care, judgment, and knowledge.

    August 21, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    He is very professional and knowledgeable and is a pleasure to work with.

    August 20, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    You can't go wrong with Dr. C. David Hansen. An all around excellent Dr. Our whole family at one point or another had him for their Dr. over the past 38 years. He was really good with the girls when they would see him. It will be sad to see him go when he decides to retire.

    August 17, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is knowledgeable, personable and caring. I havent received my results yet; however, he said it is good I came in. I appreciated the appointment as I called on Monday and on Tuesday I was in the office. I appreciate and trust Dr Hansen.

    August 16, 2023
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Caring and knowledgeable.

    See More Patient Comments

  • C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)

    Education history

    Postdoctoral Training Dermatology - Massachusetts General Hospital Postdoctoral Training
    Dermatology - University of Michigan Resident
    Internship University of Iowa Hospitals and Clinics Intern
    Medicine - University of Utah Hospital School of Medicine M.D.
    Undergraduate Chemistry - University of Utah B.S.
    Undergraduate Chemistry - University of Utah

    Selected Publications

    Journal Article

    1. Schwartz JN, Evans HA, Otoole EA, Hansen CD (2023). Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration. Keio J Med. (Read full article)
    2. Lipner SR, Falotico JM, Matushansky JT, Evans H, Schwartz J, Hansen CD (2022). Walking a day in a pachyonychia congenita patient's shoes: Impact on plantar pain and activity levels measured with wristband activity trackers. Indian J Dermatol Venereol Leprol, 89(6), 850-853. (Read full article)
    3. Tan XL, Thomas BR, Steele L, Schwartz J, Hansen CD, OToole EA (2022). Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study. J Am Acad Dermatol. (Read full article)
    4. Mathews J, Hansen CD, Chandrashekar L (2020). Homozygous dominant missense mutation in Keratin 6b leading to severe pachyonychia congenita. Clin Exp Dermatol, 46(2), 410-412. (Read full article)
    5. Samuelov L, Sarig O, Adir N, Pavlovsky M, Smith FJ, Schwartz J, Hansen CD, Sprecher E (2021). Identification of clinically useful predictive genetic variants in pachyonychia congenita. Clin Exp Dermatol, 46, 867-873. (Read full article)
    6. Stewart CL, Takeshita J, Hansen CD, Rubin AI (2020). The histopathological features of the nail plate in pachyonychia congenita. J Cutan Pathol, 47(4), 357-362. (Read full article)
    7. Goldberg I, Mashiah J, Kutz A, Derowe A, Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD (2019). Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children. Br J Dermatol, 182(3), 708-713. (Read full article)
    8. Samuelov L, Smith FJD, Hansen CD, Sprecher E (2020). Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol, 182(3), 738-746. (Read full article)
    9. Han M, Wald I, Usher W, Wu Q, Wang F, Pascucci V, Hansen CD, Johnson CR (2019). Ray Tracing Generalized Tube Primitives: Method and Applications. Eurographics Workshop Vis Comput Biomed, 38(3), 467-478. (Read full article)
    10. Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD (2012). A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol, 67(4), 680-6. (Read full article)
    11. Wilson NJ, Leachman SA, Hansen CD, McMullan AC, Milstone LM, Schwartz ME, McLean WH, Hull PR, Smith FJ (2011). A large mutational study in pachyonychia congenita. J Invest Dermatol, 131(5), 1018-24. (Read full article)
    12. Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS, Kornbrust DJ, Smith FJ, McLean WI, Milstone LM, Kaspar RL (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther, 18(2), 442-6. (Read full article)
    13. Hansen CD (1994). Advances in the Treatment of Onychomycosis. 1-3.

    Letter

    1. Steele L, Schwartz J, Hansen CD, OToole EA (2022). Prevalence and Characterization of Itch in Pachyonychia Congenita. [Letter to the editor]. JAMA Dermatol, 157(11), 1378-1380. (Read full article)
    2. Funk T, Hansen CD, Paller A, OToole EA (2019). Update on pachyonychia congenita research. [Letter to the editor]. Br J Dermatol, 182(3), 788-789. (Read full article)
    3. Wilson NJ, Prez ML, Vahlquist A, Schwartz ME, Hansen CD, McLean WH, Smith FJ (2012). Homozygous dominant missense mutation in keratin 17 leads to alopecia in addition to severe pachyonychia congenita. [Letter to the editor]. J Invest Dermatol, 132(7), 1921-4. (Read full article)

  • News & Podcasts